Burr chastises FDA at second Senate user fee hearing

Regulatory NewsRegulatory NewsBiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy